![Michal Korostynski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Michal Korostynski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Intelliseq SA
![]() Intelliseq SA Internet Software/ServicesTechnology Services Intelliseq SA is a Polish genome informatics company that specializes in creating algorithms and bioinformatic tools to interpret the human DNA sequence. The company was founded in 2014 by Marcin Piechota, Michal Korostynski, Slawomir Golda, and is currently based in Kraków, Poland. Intelliseq's interdisciplinary team of experts in genomics, molecular biology, bioinformatics, and software development aims to support whole-genome scientific research and the genetic diagnosis process. The company delivers an automatic and scalable SaaS platform for genome data analysis with no upfront cost. The company's goal is to fill a void in translating genetics knowledge into products and make DNA analysis simple. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 | - |
Fondatore | 01/01/2014 | - |
Storia della carriera di Michal Korostynski
Statistiche
Distribuzione geografica
Polonia | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Intelliseq SA
![]() Intelliseq SA Internet Software/ServicesTechnology Services Intelliseq SA is a Polish genome informatics company that specializes in creating algorithms and bioinformatic tools to interpret the human DNA sequence. The company was founded in 2014 by Marcin Piechota, Michal Korostynski, Slawomir Golda, and is currently based in Kraków, Poland. Intelliseq's interdisciplinary team of experts in genomics, molecular biology, bioinformatics, and software development aims to support whole-genome scientific research and the genetic diagnosis process. The company delivers an automatic and scalable SaaS platform for genome data analysis with no upfront cost. The company's goal is to fill a void in translating genetics knowledge into products and make DNA analysis simple. | Technology Services |
- Borsa valori
- Insiders
- Michal Korostynski
- Esperienza